|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
A new HIV-1 treatment strategy based on repeated structured treatment interruptions (STI) is currently being evaluated in clinical trials to determine whether immune cell-mediated control of viral replication can be stimulated by intermittent periods of viral replication. The potential for selection of drug-resistant quasi-species remains a major concern of such a treatment strategy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
12
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
895-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11919491-Adult,
pubmed-meshheading:11919491-Anti-HIV Agents,
pubmed-meshheading:11919491-CD4 Lymphocyte Count,
pubmed-meshheading:11919491-Drug Administration Schedule,
pubmed-meshheading:11919491-Drug Resistance, Microbial,
pubmed-meshheading:11919491-Genotype,
pubmed-meshheading:11919491-HIV Infections,
pubmed-meshheading:11919491-HIV-1,
pubmed-meshheading:11919491-Humans,
pubmed-meshheading:11919491-Mutation,
pubmed-meshheading:11919491-Phenotype,
pubmed-meshheading:11919491-RNA, Viral,
pubmed-meshheading:11919491-Viral Load
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.
|
|
pubmed:affiliation |
IrsiCaixa Foundation, Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain. javiermp@ns.hugtip.scs.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
